NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 02:51PM ET
13.24
Dollar change
+0.44
Percentage change
3.44
%
Index- P/E66.87 EPS (ttm)0.20 Insider Own11.17% Shs Outstand18.87M Perf Week1.07%
Market Cap250.24M Forward P/E65.38 EPS next Y0.20 Insider Trans0.00% Shs Float16.79M Perf Month29.93%
Enterprise Value183.94M PEG- EPS next Q0.03 Inst Own21.06% Short Float0.75% Perf Quarter39.52%
Income3.92M P/S5.76 EPS this Y47.22% Inst Trans1.14% Short Ratio3.19 Perf Half Y43.60%
Sales43.46M P/B3.92 EPS next Y52.83% ROA4.74% Short Interest0.13M Perf YTD40.40%
Book/sh3.38 P/C3.48 EPS next 5Y- ROE7.41% 52W High13.35 -0.82% Perf Year125.94%
Cash/sh3.80 P/FCF31.20 EPS past 3/5Y- - ROIC5.72% 52W Low5.67 133.51% Perf 3Y154.62%
Dividend Est.- EV/EBITDA49.45 Sales past 3/5Y11.41% 12.17% Gross Margin74.51% Volatility3.02% 4.57% Perf 5Y119.21%
Dividend TTM- EV/Sales4.23 EPS Y/Y TTM317.03% Oper. Margin4.31% ATR (14)0.54 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.75 Sales Y/Y TTM26.86% Profit Margin9.01% RSI (14)72.23 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.03 EPS Q/Q497.01% SMA2012.28% Beta1.43 Target Price15.05
Payout0.00% Debt/Eq0.09 Sales Q/Q26.84% SMA5025.99% Rel Volume0.85 Prev Close12.80
Employees120 LT Debt/Eq0.07 EarningsMay 13 BMO SMA20033.89% Avg Volume39.29K Price13.24
IPOApr 17, 2019 Option/ShortYes / Yes EPS/Sales Surpr.-11.11% 0.77% Trades Volume33,240 Change3.44%
Date Action Analyst Rating Change Price Target Change
Nov-16-23Downgrade Raymond James Outperform → Mkt Perform
Mar-03-22Initiated Loop Capital Buy $15
Jul-19-21Initiated H.C. Wainwright Buy $17
Apr-20-21Initiated Northland Capital Outperform $15
May-13-19Initiated Raymond James Outperform $14
May-13-19Initiated Oppenheimer Outperform
May-13-19Initiated Ladenburg Thalmann Buy
May-13-19Initiated Cantor Fitzgerald Overweight $17
Jun-26-25 08:36AM
Jun-24-25 09:55AM
08:54AM
Jun-19-25 09:40AM
Jun-12-25 09:15AM
07:30AM Loading…
Jun-11-25 07:30AM
Jun-10-25 08:50AM
08:00AM
Jun-05-25 09:55AM
Jun-04-25 07:30AM
May-29-25 12:20PM
May-20-25 09:55AM
May-13-25 07:30AM
May-12-25 09:31AM
May-01-25 08:00AM
08:00AM Loading…
Apr-29-25 08:00AM
Apr-02-25 03:26PM
Mar-18-25 03:04PM
Mar-12-25 03:03AM
Mar-11-25 07:30AM
Mar-04-25 08:00AM
Feb-24-25 08:00AM
Feb-17-25 09:15AM
Feb-05-25 05:59PM
Jan-22-25 09:15AM
07:39AM
Jan-15-25 12:20PM
09:55AM
Dec-26-24 09:40AM
Dec-13-24 08:15AM
08:00AM Loading…
Dec-12-24 08:00AM
Nov-20-24 08:00AM
Nov-12-24 07:30AM
Nov-11-24 07:13AM
Oct-31-24 09:40AM
Oct-29-24 08:00AM
Oct-21-24 09:55AM
09:15AM
Oct-15-24 09:40AM
Oct-10-24 07:57AM
Oct-09-24 07:30AM
Oct-04-24 09:55AM
09:15AM
Oct-01-24 08:28AM
Sep-30-24 07:30AM
Sep-16-24 07:30AM
Sep-10-24 08:00AM
Aug-30-24 12:00PM
Aug-29-24 07:30AM
Aug-26-24 09:55AM
Aug-20-24 09:40AM
Aug-19-24 09:15AM
Aug-09-24 12:20PM
Aug-08-24 09:55AM
Aug-06-24 07:30AM
Jul-25-24 07:35AM
Jul-23-24 08:00AM
Jun-19-24 09:49AM
Jun-17-24 07:30AM
Jun-14-24 09:28AM
Jun-11-24 06:20AM
Jun-10-24 07:30AM
Jun-03-24 07:30AM
May-13-24 09:55AM
May-08-24 07:30AM
Apr-24-24 08:00AM
Apr-17-24 08:00AM
Apr-04-24 08:00AM
Mar-28-24 08:00AM
Mar-27-24 09:35AM
Mar-18-24 12:00PM
07:30AM
Mar-06-24 12:52PM
07:30AM
Mar-05-24 08:20AM
Feb-21-24 08:00AM
Feb-06-24 03:51PM
Jan-25-24 08:32AM
Jan-10-24 07:30AM
Jan-03-24 08:50AM
Dec-27-23 09:55AM
Dec-22-23 09:40AM
07:10AM
Dec-19-23 07:30AM
Dec-14-23 08:50AM
Dec-11-23 09:55AM
Dec-08-23 08:16AM
Dec-07-23 08:00AM
Nov-29-23 12:00PM
Nov-28-23 01:29PM
08:50AM
Nov-23-23 09:55AM
Nov-20-23 07:30AM
Nov-15-23 07:30AM
Nov-02-23 08:00AM
Nov-01-23 08:00AM
Oct-24-23 09:40AM
Oct-16-23 07:30AM
Oct-06-23 09:40AM
Sep-27-23 08:00AM
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.